Cargando…

Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease

The recent precipitous rise in autoimmune diseases is placing an increasing clinical and economic burden on health systems worldwide. Current therapies are only moderately efficacious, often coupled with adverse side effects. Here, we show that recombinant human insulin-like growth factor-1 (rhIGF-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilbao, Daniel, Luciani, Luisa, Johannesson, Bjarki, Piszczek, Agnieszka, Rosenthal, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237469/
https://www.ncbi.nlm.nih.gov/pubmed/25339185
http://dx.doi.org/10.15252/emmm.201303376